antibodies against cxcl10 (R&D Systems)
Structured Review

Antibodies Against Cxcl10, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 21 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antibody+against+human+ip+10/bio_rxiv__2025__04__25__650709-550-22-26?v=R%26D+Systems
Average 94 stars, based on 21 article reviews
Images
1) Product Images from "Microengineered transplantation of human solid tumors for in vitro studies of CAR T immunotherapy"
Article Title: Microengineered transplantation of human solid tumors for in vitro studies of CAR T immunotherapy
Journal: bioRxiv
doi: 10.1101/2025.04.25.650709
Figure Legend Snippet: a, Conceptual diagram illustrating pairwise mapping of directional ligand-receptor interactions between different cell types in the engineered tumor model. b,c, Chord diagrams of cell pair-specific ligand-receptor interactions with adjusted p-values < 0.05 and total mean expression > 0.35. d, Visualization of interactions between CAR T cells (CAR Ts) and endothelial cells (Endos) mediated by CXCR3/DPP4-CXCL10/CXCL11. e, Violin plots comparing the expression of these mediators across all cell types. f, Experimental timeline for CAR T cell infusion and drug treatment. g, Representative confocal micrographs of single tumors treated with CAR T cells and different concentrations of LAF237. Blood vessels are not shown in these images. Scale bars, 250 μm. h, Representative images of CAR T cell-infused tumors at Day 26. Scale bars, 200 µm. i, Quantification and comparison of tumor area (top) and CAR T cell-occupied hydrogel area (bottom). Shaded in grey is a period of CAR T cell infusion and daily LAF237 treatment. Data are presented as mean ± SEM (n ≥ 3). j,k, Quantification of CXCL10 and CXCL11 levels ( j ) and the activity of DPP4 ( k ) in device effluent. Shaded in grey is a period of CAR T cell infusion and daily LAF237 treatment. Data are presented as mean ± SEM in ( j ) and as mean ± SD in ( k ) (n ≥ 3). CAR T cells derived from three healthy donors were tested in this study.
Techniques Used: Expressing, Comparison, Activity Assay, Derivative Assay

